53 related articles for article (PubMed ID: 28283987)
1. Comparative evaluation of dissolution profiles of the generic drug lamivudine 150 mg tablet marketed in Peru vs. the innovative Epivir.
Castañeda-Alarcón M; García-Montoya E; Rodríguez-Calzado J; Flores-Rodríguez M; Grande-Ortíz M; Moreno-Exebio L
Rev Peru Med Exp Salud Publica; 2024 May; 41(1):69-75. PubMed ID: 38808847
[TBL] [Abstract][Full Text] [Related]
2. Investigating the dissolution profiles of amoxicillin, metronidazole, and zidovudine formulations used in Trinidad and Tobago, West Indies.
Stuart AV; Zuo J; Löbenberg R
AAPS PharmSciTech; 2014 Oct; 15(5):1060-9. PubMed ID: 24848758
[TBL] [Abstract][Full Text] [Related]
3. The implementation of the bioequivalence certification policy in Chile: An analysis of market authorization data.
Kaplan WA; Cárdenas J; Mansilla C; Tobar T; Wirtz VJ
PLoS One; 2019; 14(5):e0217334. PubMed ID: 31141565
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Factors Related to Variation in Dissolution Profiles Estimated from Continuously Conducted Dissolution Tests of Generic Products.
Morita T; Yoshida H; Abe Y; Tomita K; Nakamura A; Hada C; Nakai C; Kina K; Takahashi M; Uemura N; Yoneda T; Yasui M; Shintani Y; Tomita N; Inagaki A; Izutsu KI; Sato Y
Chem Pharm Bull (Tokyo); 2024; 72(1):28-35. PubMed ID: 38171902
[TBL] [Abstract][Full Text] [Related]
5. Best Practices for Submission of NMR Data to Support Higher Order Structure Assessment of Generic Peptide Drugs.
Chen K; Smith CJ
AAPS J; 2023 Jan; 25(1):17. PubMed ID: 36670271
[No Abstract] [Full Text] [Related]
6. Adjusted indirect comparisons to assess bioequivalence between generic clopidogrel products in Serbia.
Pejčić Z; Vučićević K; García-Arieta A; Miljković B
Br J Clin Pharmacol; 2019 Sep; 85(9):2059-2065. PubMed ID: 31140620
[TBL] [Abstract][Full Text] [Related]
7. Implementation of a reference-scaled average bioequivalence approach for highly variable generic drug products by the US Food and Drug Administration.
Davit BM; Chen ML; Conner DP; Haidar SH; Kim S; Lee CH; Lionberger RA; Makhlouf FT; Nwakama PE; Patel DT; Schuirmann DJ; Yu LX
AAPS J; 2012 Dec; 14(4):915-24. PubMed ID: 22972221
[TBL] [Abstract][Full Text] [Related]
8. Potential concerns about generic substitution: bioequivalence versus therapeutic equivalence of different amlodipine salt forms.
Meredith PA
Curr Med Res Opin; 2009 Sep; 25(9):2179-89. PubMed ID: 19601710
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the Feasibility of Use of a Foreign Reference Product for Generic Drug Applications: A Retrospective Pilot Study.
Wang YL; Hsu LF
Eur J Drug Metab Pharmacokinet; 2017 Dec; 42(6):935-942. PubMed ID: 28283987
[TBL] [Abstract][Full Text] [Related]
10. Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration.
Davit BM; Nwakama PE; Buehler GJ; Conner DP; Haidar SH; Patel DT; Yang Y; Yu LX; Woodcock J
Ann Pharmacother; 2009 Oct; 43(10):1583-97. PubMed ID: 19776300
[TBL] [Abstract][Full Text] [Related]
11. Quantitative assessment of the switchability of generic products.
Karalis V; Bialer M; Macheras P
Eur J Pharm Sci; 2013 Nov; 50(3-4):476-83. PubMed ID: 23981332
[TBL] [Abstract][Full Text] [Related]
12. Classification of torasemide based on the Biopharmaceutics Classification System and evaluation of the FDA biowaiver provision for generic products of CLASS I drugs.
Khan MZ; Rausl D; Radosević S; Filić D; Danilovski A; Dumić M; Knezević Z
J Pharm Pharmacol; 2006 Nov; 58(11):1475-82. PubMed ID: 17132210
[TBL] [Abstract][Full Text] [Related]
13. Influence of point estimates and study power of bioequivalence studies on establishing bioequivalence between generics by adjusted indirect comparisons.
Gwaza L; Gordon J; Potthast H; Welink J; Leufkens H; Stahl M; García-Arieta A
Eur J Clin Pharmacol; 2015 Sep; 71(9):1083-9. PubMed ID: 26105964
[TBL] [Abstract][Full Text] [Related]
14. Bioequivalence between generic tacrolimus products marketed in Spain by adjusted indirect comparison.
Herranz M; Morales-Alcelay S; Corredera-Hernández MT; de la Torre-Alvarado JM; Blázquez-Pérez A; Suárez-Gea ML; Alvarez C; García-Arieta A
Eur J Clin Pharmacol; 2013 May; 69(5):1157-62. PubMed ID: 23196824
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
